As lab manager at the University of Pittsburgh Drug Discovery Institute (UPDDI), Celeste Reese and her team use high-content imaging strategies and work with many other labs both within the university and outside the university on a wide range of projects.

Automated solution unlocks the power of clinical data and accelerates LC-MS/MS workflows.

Possible pathway to adjustable filters, surfaces with variable mechanical response, or even new ways to deliver genes for biomedical applications.

Scientists at Thermo Fisher Scientific and BioAnalytix, Inc., of Cambridge, MA, are combining their expertise to develop advanced analytical profiling platforms and applications to characterize biologic and biosimilar drugs.

John Wiley & Sons, Inc., a global provider of knowledge and knowledge-enabled solutions that improve outcomes in research, professional practice, and education, announced today that it has acquired SimBioSys Inc., a provider of scientific software tools that facilitate the drug discovery process. Terms were not disclosed.

Neuroscience and cancer research added to statewide priorities: about $61 million awarded to URI since program began in 2001. Brown University, Rhode Island College, Providence College, Bryant University, Roger Williams University, Salve Regina University and CCRI are partners in RI-INBRE program.

Not when it comes to control of gene expression during dropsophila development.

Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) today announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases. The collaboration is built on an open-innovation model to bridge the gap between target discovery and pre-clinical drug development.

Not all cancer cells are created equal – some stay put in the primary tumor, while others move and invade elsewhere. A major goal for cancer research is predicting which cells will metastasize, and why

Researchers have created a prototype system that uses a mathematical model to predict - and a portable inkjet technology to produce - precise medication dosages tailored for specific patients, an advance in personalized medicine that could improve drug effectiveness and reduce adverse reactions.

June 11-12, 2014, NJ Expo Center, Edison, NJ.